Dexamethasone (Page 4 of 4)

HOW SUPPLIED

Dexamethasone Tablets, USP are available as follows:

1.5 mg tablets are supplied as a pink, round, shallow, biconvex tablet, scored on one side and debossed with “N 401” on the other side.

NDC 70954-401-10: Bottle of 100 Tablets

2 mg tablets are supplied as a white to off white, round, shallow, biconvex tablet, scored on one side and debossed with “N 402” on the other side.

NDC 70954-402-10: Bottle of 100 Tablets

4 mg tablets are supplied as a green, round, shallow, biconvex tablet, scored on one side and debossed with “N 403” on the other side.

NDC 70954-403-10: Bottle of 100 Tablets

NDC 70954-403-30: Unit dose blister packages of 100 (10 cards of 10 tablets each)

6 mg tablets are supplied as an aqua, round, shallow, biconvex tablet, scored on one side and debossed with “N 404” on the other side.

NDC 70954-404-10: Bottle of 100 Tablets

Store and Dispense

Store at 20º to 25ºC (68º to 77ºF); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight light- resistant, child-resistant container as defined in the USP/NF.

All trademarks are the property of their respective owners.

Manufactured by:

Novitium Pharma LLC

70 Lake Drive, East Windsor

New Jersey 08520

Issued: 04/2023

LB4336-01

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dexamethasone Tablets, USP 1.5 mg

NDC 70954-401-10: Bottle of 100 Tablets

image-1
(click image for full-size original)

Dexamethasone Tablets, USP 2 mg

NDC 70954-402-10: Bottle of 100 Tablets

container-2mg
(click image for full-size original)

Dexamethasone Tablets, USP 4 mg

NDC 70954-403-10: Bottle of 100 Tablets

image-2
(click image for full-size original)

NDC 70954-403-30: Unit dose blister packages of 100 (10 cards of 10 tablets each)

blister
(click image for full-size original)

carton
(click image for full-size original)

Dexamethasone Tablets, USP 6 mg

NDC 70954-404-10: Bottle of 100 Tablets

image-3
(click image for full-size original)
DEXAMETHASONE
dexamethasone tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70954-401
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DEXAMETHASONE (DEXAMETHASONE) DEXAMETHASONE 1.5 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
ANHYDROUS LACTOSE
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
D&C RED NO. 27
FD&C RED NO. 40
D&C YELLOW NO. 10
Product Characteristics
Color PINK Score 2 pieces
Shape ROUND Size 6mm
Flavor Imprint Code N401
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70954-401-10 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA215604 08/08/2022
DEXAMETHASONE
dexamethasone tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70954-403
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DEXAMETHASONE (DEXAMETHASONE) DEXAMETHASONE 4 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
ANHYDROUS LACTOSE
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
FD&C YELLOW NO. 5
FD&C BLUE NO. 1
Product Characteristics
Color GREEN Score 2 pieces
Shape ROUND Size 6mm
Flavor Imprint Code N403
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70954-403-10 100 TABLET in 1 BOTTLE None
2 NDC:70954-403-30 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (70954-403-20)
2 NDC:70954-403-20 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (70954-403-30)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA215604 08/08/2022
DEXAMETHASONE
dexamethasone tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70954-404
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DEXAMETHASONE (DEXAMETHASONE) DEXAMETHASONE 6 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
ANHYDROUS LACTOSE
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
FD&C BLUE NO. 1
D&C YELLOW NO. 10
Product Characteristics
Color BLUE (Aqua) Score 2 pieces
Shape ROUND Size 6mm
Flavor Imprint Code N404
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70954-404-10 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA215604 08/08/2022
DEXAMETHASONE
dexamethasone tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70954-402
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DEXAMETHASONE (DEXAMETHASONE) DEXAMETHASONE 2 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
ANHYDROUS LACTOSE
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
Product Characteristics
Color WHITE (White to off-white) Score 2 pieces
Shape ROUND Size 6mm
Flavor Imprint Code N402
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70954-402-10 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA217696 05/09/2023
Labeler — ANI Pharmaceuticals, Inc. (145588013)
Establishment
Name Address ID/FEI Operations
Novitium Pharma LLC 080301870 ANALYSIS (70954-401), ANALYSIS (70954-402), ANALYSIS (70954-403), ANALYSIS (70954-404), LABEL (70954-401), LABEL (70954-402), LABEL (70954-403), LABEL (70954-404), MANUFACTURE (70954-401), MANUFACTURE (70954-402), MANUFACTURE (70954-403), MANUFACTURE (70954-404), PACK (70954-401), PACK (70954-402), PACK (70954-403), PACK (70954-404)

Revised: 05/2023 ANI Pharmaceuticals, Inc.

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.